Your browser doesn't support javascript.
loading
Combining SJ733, an oral ATP4 inhibitor of Plasmodium falciparum, with the pharmacokinetic enhancer cobicistat: An innovative approach in antimalarial drug development.
Gaur, Aditya H; Panetta, John C; Smith, Amber M; Dallas, Ronald H; Freeman, Burgess B; Stewart, Tracy B; Tang, Li; John, Elizabeth; Branum, Kristen C; Patel, Nehali D; Ost, Shelley; Heine, Ryan N; Richardson, Julie L; Hammill, Jared T; Bebrevska, Lidiya; Gusovsky, Fabian; Maki, Noritsugu; Yanagi, Toshiharu; Flynn, Patricia M; McCarthy, James S; Chalon, Stephan; Guy, R Kiplin.
Afiliación
  • Gaur AH; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States. Electronic address: aditya.gaur@stjude.org.
  • Panetta JC; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Smith AM; University of Tennessee Health Science Center, Memphis, TN, United States.
  • Dallas RH; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Freeman BB; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Stewart TB; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Tang L; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • John E; EJOHN Consulting, Richland, WA, United States.
  • Branum KC; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Patel ND; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Ost S; University of Tennessee Health Science Center, Memphis, TN, United States.
  • Heine RN; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Richardson JL; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • Hammill JT; University of Kentucky College of Pharmacy, Lexington, KY, United States.
  • Bebrevska L; Medicines for Malaria Venture, Geneva, Switzerland.
  • Gusovsky F; Eisai Inc., Cambridge, MA, United States.
  • Maki N; Eisai Inc., Cambridge, MA, United States.
  • Yanagi T; Eisai Inc., Cambridge, MA, United States.
  • Flynn PM; Translational Trials Unit, MS 600, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, United States.
  • McCarthy JS; Department of Clinical Tropical Medicine, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia.
  • Chalon S; Medicines for Malaria Venture, Geneva, Switzerland.
  • Guy RK; University of Kentucky College of Pharmacy, Lexington, KY, United States.
EBioMedicine ; 80: 104065, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35598441
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Antagonistas del Ácido Fólico / Malaria / Antimaláricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Malaria Falciparum / Antagonistas del Ácido Fólico / Malaria / Antimaláricos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2022 Tipo del documento: Article